Department of Pharmaceutical Chemistry, Pharmaceutics & Pharmacognosy, University of Nairobi, P.O. Box 19676-00202, Nairobi, Kenya.
Department of Pharmacy, Kenya Methodist University, P.O. Box 19676-00202, Meru, Kenya.
BMC Complement Med Ther. 2023 Apr 3;23(1):100. doi: 10.1186/s12906-023-03939-4.
Infectious diseases are a major global public health concern as antimicrobial resistance (AMR) currently accounts for more than 700,000 deaths per year worldwide. The emergence and spread of resistant bacterial pathogens remain a key challenge in antibacterial chemotherapy. This study aims to investigate the antibacterial activity of combined extracts of various Kenyan medicinal plants against selected microorganisms of medical significance.
The antibacterial activity of various extract combinations of Aloe secundiflora, Toddalia asiatica, Senna didymobotrya and Camelia sinensis against Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae and Methicillin Resistant Staphylococcus aureus was assessed using the agar well diffusion and the minimum inhibitory concentration in-vitro assays. The checkerboard method was used to evaluate the interactions between the various extract combinations. ANOVA test followed by Tukey's post hoc multiple comparison test was used to determine statistically significant differences in activity (P < 0.05).
At concentrations of 100 mg/ml (10,000 µg/well), the different combinations of the aqueous, methanol, dichloromethane and petroleum ether extracts of the selected Kenyan medicinal plants revealed diverse activity against all the test bacteria. The combination of methanolic C. sinensis and A. secundiflora was the most active against E. coli (14.17 ± 0.22 mm, diameter of zones of inhibition (DZI); MIC 2500 µg/well). The combination of methanolic C. sinensis and S. didymobotrya was the most active against S. aureus (16.43 ± 0.10 mm; MIC 1250 µg/well), K. pneumonia (14.93 ± 0.35 mm, DZI; MIC 1250 µg/well), P. aeruginosa (17.22 ± 0.41 mm, DZI; MIC 156.25 µg/well) and MRSA (19.91 ± 0.31 mm, DZI; MIC 1250 µg/well). The Minimum Inhibitory Concentration of the different plant extract combinations ranged from 10,000 µg/ well to 156.25 µg/well. The ANOVA test indicated statistically significant differences (P < 0.05) between single extracts and their combinations. The fractional inhibitory concentration indices (FICI) showed that the interactions were either synergistic (10.5%), additive (31.6%), indifferent (52.6%), or antagonistic (5.3%) for the selected combinations.
This study findings validate the ethnopractice of selectively combining medicinal plants in the management of some bacterial infections in traditional medicine.
传染病是一个主要的全球公共卫生问题,因为目前抗生素耐药性(AMR)每年导致全球超过 70 万人死亡。耐药细菌病原体的出现和传播仍然是抗菌化疗的一个关键挑战。本研究旨在研究各种肯尼亚药用植物的组合提取物对具有医学意义的选定微生物的抗菌活性。
使用琼脂孔扩散和最小抑菌浓度(MIC)体外测定法评估 Aloe secundiflora、Toddalia asiatica、Senna didymobotrya 和 Camelia sinensis 的各种提取物组合对金黄色葡萄球菌、大肠杆菌、铜绿假单胞菌、肺炎克雷伯菌和耐甲氧西林金黄色葡萄球菌的抗菌活性。使用棋盘法评估各种提取物组合之间的相互作用。采用方差分析(ANOVA)检验和 Tukey 事后多重比较检验来确定活性的统计学差异(P < 0.05)。
在 100mg/ml(10,000μg/孔)浓度下,所选肯尼亚药用植物的水提物、甲醇提物、二氯甲烷提物和石油醚提物的不同组合对所有测试细菌均表现出不同的活性。甲醇提取物组合的茶树和龙舌兰最为活跃,对大肠杆菌的抑菌圈直径(DZI)最大(14.17±0.22mm,MIC 2500μg/孔)。甲醇提取物组合的茶树和山芝麻对金黄色葡萄球菌(16.43±0.10mm,MIC 1250μg/孔)、肺炎克雷伯菌(14.93±0.35mm,DZI,MIC 1250μg/孔)、铜绿假单胞菌(17.22±0.41mm,DZI,MIC 156.25μg/孔)和耐甲氧西林金黄色葡萄球菌(19.91±0.31mm,DZI,MIC 1250μg/孔)的活性最强。不同植物提取物组合的最小抑菌浓度(MIC)范围为 10,000μg/孔至 156.25μg/孔。方差分析(ANOVA)表明,单提取物及其组合之间存在统计学显著差异(P < 0.05)。部分抑菌浓度指数(FICI)显示,所选组合的相互作用为协同(10.5%)、相加(31.6%)、无关(52.6%)或拮抗(5.3%)。
本研究结果验证了在传统医学中选择性组合药用植物治疗某些细菌感染的民族实践。